摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-((4-(2-carboxyethyl)phenyl)thio)-1-((6-chloro-1,3-benzodioxol-5-yl)methyl)-2-(1-methylethyl)-1H-imidazole-5-carboxylic acid

中文名称
——
中文别名
——
英文名称
4-((4-(2-carboxyethyl)phenyl)thio)-1-((6-chloro-1,3-benzodioxol-5-yl)methyl)-2-(1-methylethyl)-1H-imidazole-5-carboxylic acid
英文别名
5-[4-(2-Carboxyethyl)phenyl]sulfanyl-3-[(6-chloro-1,3-benzodioxol-5-yl)methyl]-2-propan-2-ylimidazole-4-carboxylic acid
4-((4-(2-carboxyethyl)phenyl)thio)-1-((6-chloro-1,3-benzodioxol-5-yl)methyl)-2-(1-methylethyl)-1H-imidazole-5-carboxylic acid化学式
CAS
——
化学式
C24H23ClN2O6S
mdl
——
分子量
502.975
InChiKey
KQLGFTNAWIYIBA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.2
  • 重原子数:
    34
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    136
  • 氢给体数:
    2
  • 氢受体数:
    8

文献信息

  • NOUVEAUX DERIVES DE L'IMIDAZOLE, PROCEDE DE PREPARATION, COMPOSITIONS PHARMACEUTIQUES ET LEUR UTILISATION COMME ANTAGONISTES DE L'ENDOTHELINE
    申请人:Aventis Pharma S.A.
    公开号:EP0863896B1
    公开(公告)日:2005-02-09
  • METHOD AND COMPOSITION FOR TREATING DIABETIC KETOACIDOSIS
    申请人:Midwestern University
    公开号:EP2424530B1
    公开(公告)日:2015-12-16
  • Diagnostic Use of Endothelin Etb Receptor Agonists and Eta Receptor Antagonists in Tumor Imaging
    申请人:Gulati Anil
    公开号:US20080260634A1
    公开(公告)日:2008-10-23
    Methods of imaging tumors are disclosed. The methods utilize an endothelin ET B receptor agonist or an endothelin ET A receptor antagonist, in combination with an imaging agent, to detect a tumor in mammals, including humans.
  • Method and Composition for Potentiating an Opiate Analgesic
    申请人:Gulati Anil
    公开号:US20100113396A1
    公开(公告)日:2010-05-06
    Composition and methods of treating pain and reducing or reversing tolerance to opiate analgesics are disclosed. The composition and method utilize an opiate analgesic and an endothelin antagonist as active agents to treat pain in mammals, including humans.
  • Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin
    申请人:Gulati Anil
    公开号:US20100173872A1
    公开(公告)日:2010-07-08
    A composition and method of treating Alzheimer's disease or a dementia of vascular origin are disclosed. The composition and method utilize an endothelin antagonist as the active agent to treat Alzheimer's disease or a dementia of vascular origin in mammals, including humans.
查看更多